Pohlman, Sandra M. Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Pohlman, Sandra M.

Patent:
Title:
Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf
Opposition Date:
2024-04-30
Patent:
Title:
Aav-Mediated Gene Therapy Restoring The Otoferlin Gene
Opposition Date:
2024-04-19
Patent:
Title:
Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion
Opposition Date:
2022-10-04
Patent:
Title:
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer
Opposition Date:
2022-07-26
Patent:
Title:
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer
Opposition Date:
2022-05-31
Patent:
Title:
Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof
Applicant:
Opposition Date:
2022-03-22
Patent:
Title:
Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody
Opposition Date:
2021-12-10
Patent:
Title:
Process For Cultivation Of Cho Cells
Applicant:
Opposition Date:
2021-11-24
Patent:
Title:
Pharmaceutical Composition For Cancer Treatment
Opposition Date:
2021-11-17
Patent:
Title:
Subcutaneous Her2 Antibody Formulations
Applicant:
Opposition Date:
2021-06-30